Solvay has created a set of figures, which might have been meant to generate transparency but the comparable figures are pro-forma figures as if Cytec had been acquired since 1 January 2015. Sales moved up +10% to €3,052m, despite a more than €430m (estimate) push from Cytec, as prices, adverse FX developments and some divestments offset Cytec’s sales. The gross profit margin slightly improved (26.0% after 25.7%) but net income attributable to shareholders was hit by significa
03 May 2016
Babel in numbers
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Babel in numbers
Solvay SA (SOLB:WBO) | 0 0 0.5% | Mkt Cap: 11,953m
- Published:
03 May 2016 -
Author:
Martin Schnee -
Pages:
3
Solvay has created a set of figures, which might have been meant to generate transparency but the comparable figures are pro-forma figures as if Cytec had been acquired since 1 January 2015. Sales moved up +10% to €3,052m, despite a more than €430m (estimate) push from Cytec, as prices, adverse FX developments and some divestments offset Cytec’s sales. The gross profit margin slightly improved (26.0% after 25.7%) but net income attributable to shareholders was hit by significa